1996
DOI: 10.1002/(sici)1097-4652(199605)167:2<213::aid-jcp4>3.0.co;2-s
|View full text |Cite
|
Sign up to set email alerts
|

cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue

Abstract: Gene expression of soluble guanylate cyclase (sGC) and cGMP accumulation in response to sodium nitroprusside (SNP) were studied in cultured human vascular cells and freshly harvested vascular tissue. As revealed by reverse transcriptase-polymerase chain reaction, cultured smooth muscle and endothelial cells, as well as freshly isolated human vascular tissue, express mRNA for the alpha 3 and beta 3 subunits but not for the alpha 2 and beta 3 subunits is evident even in the absence of increased cGMP accumulation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0

Year Published

1999
1999
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(26 citation statements)
references
References 26 publications
0
26
0
Order By: Relevance
“…Thapsigargin stimulates the production of nitric oxide in endothelial cells, which has been reported to activate sGC and increase cGMP (9,10,58). Our studies demonstrated that thapsigargin modestly increased cGMP in cultured PAECs, an increase that was perhaps limited because sGC can be down-regulated in culture (59). Indeed, sGC is expressed in endothelial cells in vivo suggesting calcium agonists produce membrane depolarization through elevations in cGMP.…”
Section: Namentioning
confidence: 52%
“…Thapsigargin stimulates the production of nitric oxide in endothelial cells, which has been reported to activate sGC and increase cGMP (9,10,58). Our studies demonstrated that thapsigargin modestly increased cGMP in cultured PAECs, an increase that was perhaps limited because sGC can be down-regulated in culture (59). Indeed, sGC is expressed in endothelial cells in vivo suggesting calcium agonists produce membrane depolarization through elevations in cGMP.…”
Section: Namentioning
confidence: 52%
“…To date, there is limited information on the ⅐NO sensitivity of vascular beds with respect to cGMP production. Papapetropoulos and colleagues 28 investigated the response of human and animal vascular tissues to sodium nitroprusside. They found that vascular endothelium and smooth muscle cells obtained from different vascular beds had distinct cGMP responses to sodium nitroprusside.…”
Section: Ii-325mentioning
confidence: 99%
“…They found that vascular endothelium and smooth muscle cells obtained from different vascular beds had distinct cGMP responses to sodium nitroprusside. 28 One explanation offered by those investigators was a difference in guanylyl cyclase gene expression based on the vascular bed. Our study results are consistent with this contention.…”
Section: Ii-325mentioning
confidence: 99%
“…To determine whether or not the effect of pre-exposure was due to the contraction of the preparation to phenylephrine, the following experiments were performed: (i) the pre-exposure did not affect the second contractions evoked by phenylephrine itself with or without co-incubation with an antagonist of α1-adrenoceptors, phenoxybenzamine (5 × 10 −9 M, Figure 5D); and (ii) incubation for 40 min with 2 × 10 −7 M phenylephrine in the presence or absence of 10 −4 M sodium nitroprusside (to maximally stimulate the production of cyclic GMP; Papapetropoulos et al, 1996) and limit the contraction evoked by phenylephrine during the preincubation] significantly limited the contraction evoked by PGE2; after repeated washout, the basal tension of the rings was the same, regardless of the presence or absence of sodium nitroprusside (1.93 ± 0.06 and, 2.06 ± 0.05; P > 0.05). The co-incubation with sodium nitroprusside did not prevent the inhibitory effect of the pre-exposure to phenylephrine on subsequent contractions to PGE2 (data not shown).…”
Section: Role Of Pkcmentioning
confidence: 99%